Moreover, the BRCA2 mutations carriers have greater risk of bile duct, gall bladder, pancreatic, gastro-intestinal tumors, and melanoma [52], while the BRCA1 mutations carriers of CC [53]. The gene discussed is BRCA1; the disease is melanoma.